[Proposed new durg cocktail in medical therapy of chronic obliterating arteriopathy].
D018926:Anti-Allergic Agents; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D006605:Hibernation; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D007036:Hypothermia, Induced; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use*; D009539:Nicotinic Acids; D016491:Peripheral Vascular Diseases / Q000628:therapy*; D014652:Vascular Diseases
D018926:Anti-Allergic Agents; D004876:Ergot Alkaloids; D006634:Histamine H1 Antagonists; D009125:Muscle Relaxants, Central; D009539:Nicotinic Acids; D009525:Niacin
ANTIHISTAMINICS/therapeutic use; ERGOT ALKALOIDS/therapeutic use; HIBERNATION, ARTIFICIAL; MUSCLE RELAXANTS/therapeutic use; NICOTINIC ACID/therapeutic use; VASCULAR DISEASES, PERIPHERAL/therapy
Proposta di un nuovo cocktail farmacologico nella terapia medica delle arteriopatie obliteranti croniche.